Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
3.08M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
463K
-
Shares change
-
+463K
-
Total reported value, excl. options
-
$13M
-
Value change
-
+$13M
-
Number of buys
-
14
-
Price
-
$28.00
Significant Holders of Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS) as of Q3 2025
14 filings reported holding PTHS - Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.
Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 463K shares
of 3.08M outstanding shares and own 15.04% of the company stock.
Largest 10 shareholders include Murchinson Ltd. (280K shares), VANGUARD GROUP INC (66.8K shares), Ikarian Capital, LLC (62.5K shares), BOOTHBAY FUND MANAGEMENT, LLC (21.2K shares), DIADEMA PARTNERS LP (10.5K shares), GEODE CAPITAL MANAGEMENT, LLC (10.3K shares), Knott David M Jr (6.11K shares), Persistent Asset Partners Ltd (2.4K shares), Steward Partners Investment Advisory, LLC (1.91K shares), and Tower Research Capital LLC (TRC) (827 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.